HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Tatyana Korontsvit Selected Research
Tatyana Korontsvit Research Topics
Disease
22
Neoplasms (Cancer)
12/2023 - 02/2004
7
Leukemia
06/2017 - 08/2007
6
Wilms Tumor (Wilm's Tumor)
12/2023 - 08/2007
3
Bites and Stings (Sting)
11/2023 - 10/2015
3
Ovarian Neoplasms (Ovarian Cancer)
11/2023 - 05/2021
2
Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
12/2023 - 07/2010
2
Ovarian Epithelial Carcinoma
11/2023 - 05/2023
2
Melanoma (Melanoma, Malignant)
08/2020 - 06/2017
2
Mesothelioma
10/2010 - 08/2007
2
Malignant Mesothelioma
10/2010 - 08/2007
2
Hypersensitivity (Allergy)
07/2010 - 02/2004
2
BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia)
10/2005 - 02/2004
1
Hematologic Neoplasms (Hematological Malignancy)
12/2023
1
Ascites
05/2021
1
Testicular Neoplasms (Testicular Cancer)
06/2017
1
Thoracic Neoplasms
10/2010
1
Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
10/2010
1
Pathologic Complete Response
07/2010
1
Lymphoma (Lymphomas)
12/2005
1
B-Cell Lymphoma (Lymphoma, B Cell)
12/2005
1
Philadelphia Chromosome
02/2004
Drug/Important Bio-Agent (IBA)
14
Peptides (Polypeptides)
IBA
05/2021 - 02/2004
12
Antigens
IBA
12/2023 - 10/2005
6
Epitopes
IBA
11/2023 - 08/2007
5
Proteins (Proteins, Gene)
FDA Link
01/2022 - 10/2005
5
Oncogene Proteins (Oncogene Protein)
IBA
01/2017 - 08/2007
4
T-Cell Antigen Receptors (T-Cell Receptor)
IBA
12/2023 - 10/2015
4
WT1 Proteins
IBA
12/2023 - 08/2007
4
HLA-A Antigens (HLA-A)
IBA
01/2022 - 08/2014
4
Transcription Factors (Transcription Factor)
IBA
03/2013 - 08/2007
4
Vaccines
IBA
07/2011 - 02/2004
4
Protein Subunit Vaccines
IBA
07/2010 - 02/2004
3
Chimeric Antigen Receptors
IBA
12/2023 - 05/2023
3
Neoplasm Antigens (Tumor Antigens)
IBA
11/2023 - 01/2017
3
Interferon-gamma (Interferon, gamma)
IBA
10/2010 - 02/2004
2
RMFPNAPYL
IBA
11/2023 - 05/2023
2
HLA-A2 Antigen (HLA A2 Antigen)
IBA
11/2023 - 05/2023
2
HLA Antigens (Human Leukocyte Antigens)
IBA
05/2021 - 12/2019
2
Ligands
IBA
05/2021 - 12/2019
2
Histocompatibility Antigens Class I
IBA
12/2019 - 01/2008
2
Antibodies
IBA
06/2017 - 08/2014
2
Monoclonal Antibodies
IBA
10/2015 - 08/2014
2
Enzymes
IBA
08/2007 - 02/2004
1
Phosphopeptides
IBA
01/2022
1
RNA (Ribonucleic Acid)
IBA
05/2021
1
Actinium-225
IBA
08/2020
1
Antineoplastic Agents (Antineoplastics)
IBA
08/2020
1
Melanocyte-Stimulating Hormones (MSH)
IBA
08/2020
1
Radioisotopes (Radionuclides)
IBA
08/2020
1
Silicon Dioxide (Silica)
FDA Link
Generic
08/2020
1
Type 1 Melanocortin Receptor
IBA
08/2020
1
Phosphotransferases (Kinase)
IBA
12/2019
1
Immunoglobulin G (IgG)
IBA
07/2011
1
Carbon Nanotubes (Carbon Nanotube)
IBA
07/2011
1
Cytokines
IBA
10/2010
1
HLA-DR Antigens (HLA-DR)
IBA
08/2009
1
Cyclin D1
IBA
08/2009
1
HLA-DRB1 Chains (HLA DRB1)
IBA
08/2007
1
Interleukin-18 (Interleukin 18)
IBA
12/2005
1
Interferons
IBA
02/2004
1
Interferon-alpha (Interferon Alfa)
IBA
02/2004
1
Imatinib Mesylate (Gleevec)
FDA Link
02/2004
Therapy/Procedure
5
Immunotherapy
05/2021 - 08/2007
3
Therapeutics
12/2023 - 07/2010
1
Cell- and Tissue-Based Therapy (Cell Therapy)
10/2015
1
Transplantation
02/2004
1
Bone Marrow Transplantation (Transplantation, Bone Marrow)
02/2004